Enabling Direct Therapeutic Access Beyond the Blood-Brain Barrier BALTIMORE, /PRNewswire/ -- CraniUS Therapeutics LLC, a privately held neurotechnology company, today announced it has raised $20 ...

Delivering therapies to the brain remains a major challenge due to the limited permeability of the blood-brain barrier. In a ...

The human brain comprises billions of neurons, synapses, and cell types, making it one of the universe's most intricate and dynamic structures. However, the complexity and sensitivity of the brain can ...

A team of Canadian scientists has uncovered a new way to slow the growth of glioblastoma, the most aggressive and currently ...

The Preston Robert Tisch Brain Tumor Center grants first IRB approval for APTN-101’s Phase I clinical trial, enabling patient ...

Researchers developed nanotechnology that selectively binds and degrades abnormal proteins. The technology shows promise for ...

Modern cancer therapies have resulted in higher survival rates for victims of this dread disease, in many cases. However, their generic mode of delivery and action is associated with greater adverse ...

Patients who received a focused ultrasound treatment to aid drug delivery increased their odds of surviving the deadliest form of brain cancer by nearly 40%, according to a study led by University of ...

A man with the deadliest form of brain cancer has no signs of the disease after taking an experimental drug. Ben Trotman was 40 when he was diagnosed in 2022 with glioblastoma, the most aggressive ...

The human brain comprises billions of neurons, synapses, and cell types, making it one of the universe’s most intricate and dynamic structures. However, the complexity and sensitivity of the brain can ...